L
Leslie G. Ford
Researcher at National Institutes of Health
Publications - 90
Citations - 21684
Leslie G. Ford is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 41, co-authored 87 publications receiving 19931 citations. Previous affiliations of Leslie G. Ford include University of Texas Health Science Center at San Antonio & Walter Reed Army Institute of Research.
Papers
More filters
Journal ArticleDOI
Estrogen Replacement Therapy in Breast Cancer Survivors
TL;DR: The article provided limited evidence on ERT safety for breast cancer survivors and data on recurrence and survival effects were presented but were limited to studies of "past" or "ever recorded" ERT use.
Journal ArticleDOI
Report from an NCI Roundtable: Cancer Prevention in Primary Care
Goli Samimi,Jasmine Douglas,Brandy M. Heckman-Stoddard,Leslie G. Ford,Eva Szabo,Lori M. Minasian +5 more
TL;DR: The Division of Cancer Prevention in the NCI sponsored a Roundtable with primary care providers to determine barriers for integrating cancer prevention within primary care and discuss potential opportunities to overcome them.
Journal ArticleDOI
The role of thematic evaluation in program assessment: the case of the community clinical oncology program
Dennis Gillings,Thomas C. Ricketts,Janet Barnsley,Arnold D. Kaluzny,Leslie G. Ford,Richard B. Warnecke,Edward J. Sondik +6 more
TL;DR: This paper describes the application of the thematic approach to the evaluation of a complex, community-oriented cancer research program.
Posted ContentDOI
Genomic risk prediction for breast cancer in older women
Paul Lacaze,Andrew Bakshi,Suzanne G Orchard,Jane Tiller,Johannes T Neumann,Prudence R. Carr,Amit Joshi,Yin Cao,Erica T. Warner,Alisa K. Manning,Tu Nguyen-Dumont,Melissa C. Southey,Roger L. Milne,Leslie G. Ford,Robert Sebra,Eric E. Schadt,Lucy Gately,Peter Gibbs,Bryony A. Thompson,Finlay A. Macrae,Paul A. James,Ingrid Winship,Catriona McLean,John Zalcberg,Robyn L. Woods,Andrew T. Chan,Anne M. Murray,John J McNeil +27 more
TL;DR: In this paper, the effect of a 313-variant polygenic risk score (PRS) for breast cancer in 6,339 women of European ancestry aged ≥70 years was assessed.
Journal ArticleDOI
A systematic review and pooled analysis of hypothesized versus observed effect sizes in early phase cancer prevention clinical trials.
Jens C. Eickhoff,Guanhua Chen,Vikrant V. Sahasrabuddhe,Leslie G. Ford,Eva Szabo,KyungMann Kim +5 more
TL;DR: The authors conducted a systematic review and pooled analyses of recently completed early phase chemoprevention trials to gain in depth insight on the failure of detecting efficacy signals by comparing hypothesized effect sizes to the corresponding observed effect sizes.